FONR Fundamental Analysis - FONAR CORP

Fundamental Rating

We assign a fundamental rating of 5 out of 10 to FONR. FONR was compared to 190 industry peers in the Health Care Equipment & Supplies industry. FONR is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. FONR is valued correctly, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year FONR was profitable.

In the past year FONR had a positive cash flow from operations.

FONR had positive earnings in each of the past 5 years.

In the past 5 years FONR always reported a positive cash flow from operatings.

1.2 Ratios

FONR has a better Return On Assets (3.60%) than 78.42% of its industry peers.

With a decent Return On Equity value of 4.52%, FONR is doing good in the industry, outperforming 75.79% of the companies in the same industry.

FONR's Return On Invested Capital of 4.37% is fine compared to the rest of the industry. FONR outperforms 74.21% of its industry peers.

FONR had an Average Return On Invested Capital over the past 3 years of 5.58%. This is below the industry average of 8.88%.

		Industry Rank	Sector Rank
ROA	3.6%
ROE	4.52%
ROIC	4.37%

ROA(3y)4.2%

ROA(5y)4.71%

ROE(3y)5.35%

ROE(5y)6.16%

ROIC(3y)5.58%

ROIC(5y)6.68%

1.3 Margins

FONR has a better Profit Margin (7.48%) than 78.42% of its industry peers.

In the last couple of years the Profit Margin of FONR has declined.

The Operating Margin of FONR (11.11%) is better than 78.42% of its industry peers.

In the last couple of years the Operating Margin of FONR has declined.

With a Gross Margin value of 41.11%, FONR is not doing good in the industry: 65.26% of the companies in the same industry are doing better.

FONR's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	11.11%
PM (TTM)	7.48%
GM	41.11%

OM growth 3Y-21%

OM growth 5Y-7.01%

PM growth 3Y-14.56%

PM growth 5Y-3.61%

GM growth 3Y-5.13%

GM growth 5Y-3.63%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FONR is destroying value.

FONR has less shares outstanding than it did 1 year ago.

The number of shares outstanding for FONR has been reduced compared to 5 years ago.

Compared to 1 year ago, FONR has an improved debt to assets ratio.

2.2 Solvency

FONR has an Altman-Z score of 2.66. This is not the best score and indicates that FONR is in the grey zone with still only limited risk for bankruptcy at the moment.

The Altman-Z score of FONR (2.66) is better than 63.68% of its industry peers.

The Debt to FCF ratio of FONR is 0.05, which is an excellent value as it means it would take FONR, only 0.05 years of fcf income to pay off all of its debts.

FONR has a better Debt to FCF ratio (0.05) than 94.74% of its industry peers.

FONR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.

Looking at the Debt to Equity ratio, with a value of 0.00, FONR is in the better half of the industry, outperforming 74.74% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0.05
Altman-Z	2.66

ROIC/WACC0.51

WACC8.59%

2.3 Liquidity

A Current Ratio of 8.45 indicates that FONR has no problem at all paying its short term obligations.

The Current ratio of FONR (8.45) is better than 89.47% of its industry peers.

FONR has a Quick Ratio of 8.28. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.

FONR's Quick ratio of 8.28 is amongst the best of the industry. FONR outperforms 91.05% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	8.45
Quick Ratio	8.28

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

FONR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.77%.

Measured over the past 5 years, FONR shows a small growth in Earnings Per Share. The EPS has been growing by 0.90% on average per year.

The Revenue has been growing slightly by 1.42% in the past year.

FONR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.02% yearly.

EPS 1Y (TTM)-19.77%

EPS 3Y-11.06%

EPS 5Y0.9%

EPS Q2Q%-11.84%

Revenue 1Y (TTM)1.42%

Revenue growth 3Y2.25%

Revenue growth 5Y4.02%

Sales Q2Q%5.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.36, the valuation of FONR can be described as correct.

88.95% of the companies in the same industry are more expensive than FONR, based on the Price/Earnings ratio.

Compared to an average S&P500 Price/Earnings ratio of 27.57, FONR is valued rather cheaply.

		Industry Rank	Sector Rank
PE	13.36
Fwd PE	N/A

4.2 Price Multiples

FONR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. FONR is cheaper than 98.42% of the companies in the same industry.

Based on the Price/Free Cash Flow ratio, FONR is valued cheaper than 95.26% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	13.13
EV/EBITDA	2.58

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)14.83

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

FONR does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

FONAR CORP

NASDAQ:FONR (10/22/2025, 8:00:00 PM)

After market: 15.5 0 (0%)

15.5

-0.08 (-0.51%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)09-30 2025-09-30

Earnings (Next)11-10 2025-11-10

Inst Owners47.25%

Inst Owner Change0%

Ins Owners5.07%

Ins Owner Change0%

Market Cap97.81M

Revenue(TTM)104.35M

Net Income(TTM)7.81M

Analysts0

Price TargetN/A

Short Float %1%

Short Ratio4.27

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	13.36
Fwd PE	N/A
P/S	0.94
P/FCF	13.13
P/OCF	8.68
P/B	0.57
P/tB	0.59
EV/EBITDA	2.58

EPS(TTM)1.16

EY7.48%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)1.18

FCFY7.62%

OCF(TTM)1.79

OCFY11.52%

SpS16.54

BVpS27.35

TBVpS26.2

PEG (NY)N/A

PEG (5Y)14.83

Graham Number26.72

Profitability

		Industry Rank	Sector Rank
ROA	3.6%
ROE	4.52%
ROCE	5.81%
ROIC	4.37%
ROICexc	6.09%
ROICexgc	6.42%
OM	11.11%
PM (TTM)	7.48%
GM	41.11%
FCFM	7.14%

ROA(3y)4.2%

ROA(5y)4.71%

ROE(3y)5.35%

ROE(5y)6.16%

ROIC(3y)5.58%

ROIC(5y)6.68%

ROICexc(3y)7.78%

ROICexc(5y)9.2%

ROICexgc(3y)8.22%

ROICexgc(5y)9.77%

ROCE(3y)7.41%

ROCE(5y)8.87%

ROICexgc growth 3Y-21.28%

ROICexgc growth 5Y-6.2%

ROICexc growth 3Y-21.03%

ROICexc growth 5Y-5.92%

OM growth 3Y-21%

OM growth 5Y-7.01%

PM growth 3Y-14.56%

PM growth 5Y-3.61%

GM growth 3Y-5.13%

GM growth 5Y-3.63%

F-Score7

Asset Turnover0.48

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0.05
Debt/EBITDA	0.01
Cap/Depr	81.24%
Cap/Sales	3.66%
Interest Coverage	453.04
Cash Conversion	69.13%
Profit Quality	95.41%
Current Ratio	8.45
Quick Ratio	8.28
Altman-Z	2.66

F-Score7

WACC8.59%

ROIC/WACC0.51

Cap/Depr(3y)64.91%

Cap/Depr(5y)77.48%

Cap/Sales(3y)2.95%

Cap/Sales(5y)3.54%

Profit Quality(3y)114.83%

Profit Quality(5y)119.2%

High Growth Momentum

Growth

EPS 1Y (TTM)-19.77%

EPS 3Y-11.06%

EPS 5Y0.9%

EPS Q2Q%-11.84%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)1.42%

Revenue growth 3Y2.25%

Revenue growth 5Y4.02%

Sales Q2Q%5.14%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-29.86%

EBIT growth 3Y-19.22%

EBIT growth 5Y-3.28%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-43.88%

FCF growth 3Y-11.29%

FCF growth 5Y-10.21%

OCF growth 1Y-20.07%

OCF growth 3Y-9.7%

OCF growth 5Y-11.2%

FONAR CORP (FONR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens